(Q44257745)

1 December 2017

title

Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus (English)

1 reference

1 December 2017

0 references

1 reference

Vickers MA

1

1 reference

1 December 2017

Satyanarayana R

series ordinal

2

1 reference

1 December 2017

publication date

1 December 2002

1 reference

International Journal of Impotence Research

1 December 2017

published in

1 reference

1 December 2017

volume

14

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

466-471

1 reference

Apoptosis in the erectile tissues of diabetic and healthy rats.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Radicals and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900910

21 January 2018

Identifiers

DOI

10.1038/SJ.IJIR.3900910

1 reference

1 December 2017

1 reference